Research Overview
Armin Gamper investigates DNA damage response pathways and develops pharmacological strategies targeting DDR for personalized cancer medicine. His research focuses on understanding how DNA repair mechanisms can be exploited for therapeutic benefit.
DNA Damage ResponseDDR PathwaysProtein ChemistryDrug Development
Research Focus
DDR Pathways
Investigation of DNA damage response pathways and their regulation in cancer cells for therapeutic targeting.
Protein Chemistry
Study of protein interactions and modifications involved in DNA damage response and repair mechanisms.
Drug Development
Development of novel pharmacological strategies that target DNA damage response pathways for cancer treatment.
Personalized Medicine
Application of DDR research to develop personalized cancer medicine approaches based on individual tumor characteristics.